- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Results
4
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
4 companies
Alembic Pharmaceuticals
Market Cap: ₹166.4b
Develops, manufactures, and markets pharmaceutical products in India and internationally.
APLLTD
₹846.40
7D
-4.0%
1Y
-13.9%
SSY Group
Market Cap: HK$9.0b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.06
7D
3.0%
1Y
-36.3%
Biotage
Market Cap: SEK 7.2b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 90.40
7D
4.8%
1Y
-47.6%
MedCap
Market Cap: SEK 5.6b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.
MCAP
SEK 370.50
7D
9.5%
1Y
-9.9%